After 45% Rally Can Stryker Stock See More Gains?

After a 45% rally off the March bottom, Stryker stock, a company best known for its implants used in joint replacement and trauma surgeries, looks fully valued based on its historic P/E multiples. Stryker stock has rallied from $126 to $183 off the recent bottom compared to the S&P which moved…

About the Author

has written 23544 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com